Charles G Macias1, Jonathan M Mansbach2, Erin S Fisher3, Mark Riederer4, Pedro A Piedra5, Ashley F Sullivan6, Janice A Espinola6, Carlos A Camargo6. 1. Department of Pediatrics, Section of Emergency Medicine, and Center for Clinical Effectiveness, Texas Children's Hospital, Baylor College of Medicine, Houston, Tex. Electronic address: cgmacias@texaschildrens.org. 2. Department of Medicine, Children's Hospital Boston, Harvard Medical School, Boston, Mass. 3. Department of Pediatrics, Rady Children's Hospital, University of California, San Diego, Calif. 4. Department of Pediatrics, Children's Hospital of Colorado, Denver, Colo. 5. Departments of Molecular Virology and Microbiology, and Pediatrics, Baylor College of Medicine, Houston, Tex. 6. Department of Emergency Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Mass.
Abstract
OBJECTIVE: To determine the variability between hospitals in diagnostic testing and management interventions for children with bronchiolitis admitted to inpatient wards and identify its association with patient characteristics. METHODS: A prospective, multicenter (16 hospitals), multiyear (2007-2010) observational study of children (age <2 years) hospitalized with bronchiolitis. Outcomes included variability in diagnostic testing (complete blood count, chest radiographs) and medications or interventions (bronchodilator, systemic corticosteroid, antibiotic, IV placement) by hospital. A modified Respiratory Distress Severity Score was utilized to assess severity of illness. For all outcomes, intraclass correlation coefficient (ICC) was calculated from a model to estimate the random effects of hospital without added covariates and compared to ICCs from a second model that adjusted for demographic and clinical patient characteristics. A second unadjusted and adjusted model was created for age ≥ 2 months. RESULTS: Of 2207 subjects, 1715 were identified as admitted to inpatient wards. We observed wide variations in the proportion of patients who received diagnostic testing (complete blood count 21-75%, chest radiograph 36-85%) and medications/interventions (bronchodilators 19-91%, systemic corticosteroids 8-44%, antibiotics 17-43%, IV placement 38-93%). Adjusting for demographic and clinical patient characteristics did not materially affect the proportion of variability attributable to hospitals (differences in ICCs with and without model adjustment <4%). CONCLUSIONS: Wide variations in diagnostic test utilization and management interventions seen among children with bronchiolitis treated on the inpatient wards at 16 US hospitals were not attributable to demographic or clinical patient characteristics. These results further support efforts to standardize care for bronchiolitis through active quality improvement strategies.
OBJECTIVE: To determine the variability between hospitals in diagnostic testing and management interventions for children with bronchiolitis admitted to inpatient wards and identify its association with patient characteristics. METHODS: A prospective, multicenter (16 hospitals), multiyear (2007-2010) observational study of children (age <2 years) hospitalized with bronchiolitis. Outcomes included variability in diagnostic testing (complete blood count, chest radiographs) and medications or interventions (bronchodilator, systemic corticosteroid, antibiotic, IV placement) by hospital. A modified Respiratory Distress Severity Score was utilized to assess severity of illness. For all outcomes, intraclass correlation coefficient (ICC) was calculated from a model to estimate the random effects of hospital without added covariates and compared to ICCs from a second model that adjusted for demographic and clinical patient characteristics. A second unadjusted and adjusted model was created for age ≥ 2 months. RESULTS: Of 2207 subjects, 1715 were identified as admitted to inpatient wards. We observed wide variations in the proportion of patients who received diagnostic testing (complete blood count 21-75%, chest radiograph 36-85%) and medications/interventions (bronchodilators 19-91%, systemic corticosteroids 8-44%, antibiotics 17-43%, IV placement 38-93%). Adjusting for demographic and clinical patient characteristics did not materially affect the proportion of variability attributable to hospitals (differences in ICCs with and without model adjustment <4%). CONCLUSIONS: Wide variations in diagnostic test utilization and management interventions seen among children with bronchiolitis treated on the inpatient wards at 16 US hospitals were not attributable to demographic or clinical patient characteristics. These results further support efforts to standardize care for bronchiolitis through active quality improvement strategies.
Authors: Michimasa Fujiogi; Tadahiro Goto; Hideo Yasunaga; Jun Fujishiro; Jonathan M Mansbach; Carlos A Camargo; Kohei Hasegawa Journal: Pediatrics Date: 2019-11-07 Impact factor: 7.124
Authors: Elizabeth R Wolf; Alicia Richards; Martin Lavallee; Roy T Sabo; Alan R Schroeder; Matthew Schefft; Alex H Krist Journal: Pediatrics Date: 2021-09-23 Impact factor: 9.703
Authors: Mersine A Bryan; Annika M Hofstetter; M Patricia deHart; Tamara D Simon; Douglas J Opel Journal: Pediatrics Date: 2019-10-17 Impact factor: 7.124
Authors: Timothy J D Ohlsen; Alexander M Knudson; E Kent Korgenski; David R Sandweiss; Michelle G Hofmann; Tiffany S Glasgow; Eric R Coon Journal: J Hosp Med Date: 2021-05 Impact factor: 2.960
Authors: Elisa Barbieri; Anna Cantarutti; Sara Cavagnis; Luigi Cantarutti; Eugenio Baraldi; Carlo Giaquinto; Daniele Donà Journal: NPJ Prim Care Respir Med Date: 2021-03-19 Impact factor: 2.871
Authors: Varpu Elenius; Eija Bergroth; Petri Koponen; Sami Remes; Pedro A Piedra; Janice A Espinola; Matti Korppi; Carlos A Camargo; Tuomas Jartti Journal: Acta Paediatr Date: 2017-06-16 Impact factor: 2.299
Authors: Anna Condella; Jonathan M Mansbach; Kohei Hasegawa; Peter S Dayan; Ashley F Sullivan; Janice A Espinola; Carlos A Camargo Journal: West J Emerg Med Date: 2018-04-05